Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia

Autor: Wieslaw Jakobowiak, Nina Khurieva, Peremitin Gg, Rosella Centis, Manfred Danilovits, Giovanni Battista Migliori, Katherine Floyd, Raymond Hutubessy, Kai Kliiman, Salmaan Keshavjee

Publikováno v: European Respiratory Journal. 40:133-142

Evidence on the cost and cost-effectiveness of treatment of multidrug-resistant tuberculosis (MDR-TB) is limited, and no published data are available from former Soviet Union countries, where rates of MDR-TB are highest globally. We evaluated the cos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::554ad4da4d2f21f2195fbb9c387691c0
https://doi.org/10.1183/09031936.00169411

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Adverse reactions among patients being treated for MDR-TB in Tomsk, Russia.

Autor: Shin SS; Division of Social Medicine and Health Inequalities, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. sshin@partners.org, Pasechnikov AD, Gelmanova IY, Peremitin GG, Strelis AK, Mishustin S, Barnashov A, Karpeichik Y, Andreev YG, Golubchikova VT, Tonkel TP, Yanova GV, Yedilbayev A, Rich ML, Mukherjee JS, Furin JJ, Atwood S, Farmer PE, Keshavjee S

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease [Int J Tuberc Lung Dis] 2007 Dec; Vol. 11 (12), pp. 1314-20.

[Laboratory service optimization in the implementation of a complex programme for detection and treatment patients with tuberculosis].

Autor: Strelis AK, Peremitin GG, Ianova GV, Pavlova VE, Golubchikova VT, Ovsiannikova TN, Sirotkina OB, Tonkel TP, Strelis AA, Pasechnikov AD

Publikováno v: Klinicheskaia laboratornaia diagnostika [Klin Lab Diagn] 2005 Apr (4), pp. 38-40.